|
Mechanismfungal CYP51A1 inhibitors |
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.US |
First Approval Date18 Feb 1983 |
100 Clinical Results associated with Shanghai Golden Pharmatech Co., Ltd.
0 Patents (Medical) associated with Shanghai Golden Pharmatech Co., Ltd.
100 Deals associated with Shanghai Golden Pharmatech Co., Ltd.
100 Translational Medicine associated with Shanghai Golden Pharmatech Co., Ltd.